AGP Executive Report
Last update: 10 hours agoPharmaceutical Investment: CEDA says CNMI Investment LLC can seek changes to its governor-signed tax agreement, after the company warned restrictions could make its proposed Saipan drug-manufacturing project unworkable. Product Safety: The FDA warned that recalled male-enhancement supplements containing undeclared prescription drugs were sold in the CNMI; hidden ingredients can dangerously interact with nitrate medications. Cancer Care: A Saipan oncologist says immunotherapy combined with targeted medication has shrunk betel nut-related oral tumors in an estimated 75% to 80% of patients treated, and his team is preparing a clinical trial to assess longer-term results. Amputation Prevention: Guam and CNMI health professionals met Saturday to discuss earlier detection and coordinated care to prevent diabetes- and circulation-related amputations. Community Health: Free blood pressure and blood sugar checks return to Saipan’s Oleai Beach Pavilion on Nov. 18. Veterans’ Care: The U.S. House passed legislation that includes CNMI Delegate Kimberlyn King-Hinds’ measures to expand veterans’ access to care in the territories and Pacific island nations; local officials also say Saipan’s veterans clinic is nearing its opening.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.